Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:983 (3 May), doi:10.1136/bmj.39566.573079.4E
Lynn Eaton
1 London
| The first 150 words of the full text of this article appear below. |
The government should take action to stop dangerous prescribing of antipsychotic drugs to people with dementia, says a report from a group of MPs.
The all party parliamentary group on dementia says that the government should use its national dementia strategy, which is due to be published in October, to tackle the problem and that the National Institute for Health and Clinical Excellence should review use of the drugs.
"Antipsychotics can double the risk of death and triple the risk of stroke in people with dementia, heavily sedate them, and accelerate cognitive decline," said Jeremy Wright, the groups chairman. "Best practice guidelines are not enough: safeguards must be put in place to ensure antipsychotics are always a last resort."
A lack of support from appropriate specialists can lead to people going for a long time without any review of their treatment, says the report. As a result, prescriptions are not
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+